Tiantan bio | Briefing, News, Analysis, Research, Data

Tiantan bio

Tiantan bio diagnostic supplies and other biological products

Tiantan Bio is a vaccine reagent developer, focusing on the research and production of vaccines, blood preparations, diagnostic supplies and other biological products, mainly to provide users with hepatitis B vaccine, polio vaccine, MMR vaccine, influenza vaccine, chickenpox vaccine and other products, its own Changchun Chijian Biological Products Co.

Sector

Healthcare

Industry

Biotech/Pharma

Sub-industry

Founded

Jun 8, 1998

HQ location

Beijing, China

Legal name

Beijing Tiantan Biological Products Corporation Limited

Website

http://www.tiantanbio.com/

ttsw@sinopharm.com

Employees

1001-5000

All
News
Analysis
Research

Briefing Sep 21, 2022 10:38 AM · Healthcare

Weiyou Gene Nets Tens of Millions of CNY in Series Pre-A Round

Briefing Sep 16, 2022 11:10 PM · Healthcare

NaviSeed Nets Tens of millions of CNY in Angel Round

In-depth

Healthcare

Immunotherapy in China: A Rising Star in the Field of Cancer Treatment

Immunotherapy is emerging as a powerful weapon in fighting cancer by restarting and maintaining the cancer-immunity cycle to identify, control and eliminate tumor cells rather than killing them directly.

Nov 24, 2022 06:29 PM

Briefing Sep 13, 2022 05:30 PM · Healthcare

Nuwacell Nets Hundreds of Mns of CNY in Series A

Briefing Aug 31, 2022 08:30 PM · Healthcare

Enitiatebio Nets One Hundred Million of CNY in Series A Round

Research

Healthcare

Digital Therapeutics - Revolution of the healthcare system

Nov 16, 2022 05:19 PM

Research

Healthcare

2022 China AI Health 30 Report

Nov 07, 2022 04:27 PM

Research

Healthcare

2022 China’s Healthcare Industry: An Introductory Handbook

Aug 29, 2022 05:45 PM

Research

Technology, Healthcare, Financials

WIA2020 | 30 Tech Entrepreneurs in China

Apr 22, 2021 03:11 PM

Briefing Jun 28, 2022 09:56 AM · Healthcare

And platinum medicine b7h4x4-1bb bispecific antibody were approved by FDA for new drug research

Briefing Jun 28, 2022 09:54 AM · Healthcare

Fosun pharma and Amgen have reached cooperation to accelerate the commercialization of two innovative drugs in China

Briefing Jun 28, 2022 09:50 AM · Healthcare

It is expected to achieve functional cure of chronic hepatitis B! GSK antisense therapy phase IIB positive clinical results

Briefing Jun 28, 2022 09:37 AM · Healthcare

Aibo biology: cooperate with Jiahe biology to jointly develop tumor mRNA drugs

Healthcare

Pre-clinical CRO ZHSK Lab Nets Over CNY 100 Mn in Series B

ZSHK, a pre-clinical Contract Research Organization (“Preclinical CRO”), raised funds from AZ-CICC and its existing investor Jishi Capital to enhance international deployment and key resources construction

Updated 4 hours ago

Healthcare

Biotech Primelink Nets Over CNY 100 Mn

As a new star in the antibody-drug conjugate (“ADC”) industry, Primelink plans to build a more flexible ADC technology platform.

Updated 4 hours ago

Briefing Jun 24, 2022 11:15 AM · Healthcare

F-star to be acquired by China biopharmaceutical with USD 161million

Briefing May 23, 2022 11:10 AM · Healthcare | Industrials | Financials

Monitoring of main funds of star mine: Top 10 list of early trading

Briefing Apr 25, 2022 06:35 PM · Healthcare | Financials | Automotive

Nanomicro Technology: first release of a new product of protein A affinity chromatography medium

Healthcare

Fully Native Human mAb Drug Developer Trinomab Raises CNY 750 Mn in Pre-IPO Round

Despite increasing competition, the prospect of the monoclonal antibody drug market in China remains promising.

Nov 29, 2022 05:53 PM

Healthcare

Biotech Rgenta Wins USD 52 Mn in Series A Funding Round

The precise regulation of RNA target sites is expected to regulate protein expression from upstream, intervene in traditionally undruggable targets, and control diseases.

Nov 29, 2022 01:02 PM

Briefing Mar 15, 2022 06:19 PM · Healthcare | Financials

It is said that Yin Xiyue will not send special envoys to China, Russia and Japan, but only to the United States and the European Union

Briefing Jan 13, 2022 05:49 PM · Financials | Technology | Consumer Staples

Guangdong Securities Regulatory Bureau issued a warning letter to Zhengzhong Zhujiang certified public accountants

Briefing Oct 20, 2021 06:11 PM

Five departments including the central bank: encourage financial institutions to incorporate the application of open source technology into their informatization development plans

Briefing Mar 29, 2021 09:30 PM · Technology | Consumer Staples | Real Estate

Annual report of Shanghai Hong Kong Group: net profit in 2020 decreased by 8.33% year-on-year, and it is planned to pay 1.28 yuan for 10 shares

EqualOcean Analysis